Management of Cutaneous Tumors with Mohs Micrographic Surgery

ABSTRACT

Since the inception of Mohs micrographic surgery in the 1930s, this technique has proved its utility in the treatment of cutaneous tumors. This review describes the technique of Mohs micrographic surgery and the various indications for which it is used. We discuss the use of Mohs micrographic surgery for the following cutaneous tumors: basal cell carcinoma, squamous cell carcinoma, melanoma in situ, dermatofibrosarcoma protuberans, Merkel cell carcinoma, microcystic adnexal carcinoma, atypical fibroxanthoma, and sebaceous carcinoma. Mohs micrographic surgery is cost effective in the U.S. health care system because billing for the surgeon-pathologist and laboratory processing is bundled together. However, Mohs micrographic surgery may be more expensive in European systems because the Mohs technique surgeon, pathologist, and laboratory fees may be billed separately.

KEYWORDS

Mohs micrographic surgery - cutaneous oncology - skin cancer

REFERENCES

• 1 Mohs F E. Mohs micrographic surgery: a historical perspective.  Dermatol Clin. 1989;  7 609-611
• 2 Brodland D G, Amonette R, Hanke C W, Robins P. The history and evolution of Mohs micrographic surgery.  Dermatol Surg. 2000;  26 303-307
• 3 Mohs F E. Chemosurgery: a microscopically controlled method of cancer excision.  Arch Surg. 1941;  42 279
• 4 Mohs F E. History of Mohs micrographic surgery. In: Roenigk RK, Roenigk HH Dermatologic Surgery: Principles and Practice. New York, NY; Marcel Dekker 1989: 783-789
• 5 Tromovitch T A, Stegman S J. Microscopically controlled excision of skin tumors: chemosurgery (Mohs): fresh tissue technique.  Arch Dermatol. 1974;  110 231-232
• 6 McGillis S T, Wheeland R G, Sebben J E. Current issues in the performance of Mohs micrographic surgery.  J Dermatol Surg Oncol. 1991;  17 681-684
• 7 Shriner D L, McCoy D K, Goldberg D J, Wagner Jr R F. Mohs micrographic surgery: clinical review.  J Am Acad Dermatol. 1998;  39 79-97
• 8 Pennington B, Brent M R. Nonmelanoma of the skin and Mohs surgery.  Plast Reconstr Surg. 2004;  113 2233-2234
• 9 Rigel DS Cancer of the Skin. Philadelphia, PA; Elsevier 2005: 167-173
• 10 Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma.  Br J Dermatol. 2002;  146 18-25
• 11 Morman M R. Mohs micrographic surgery.  N J Med. 1989;  86 369-373
• 12 Dzubow L M. Mohs surgery.  Lancet. 1994;  343 433-434
• 13 Robinson J K. Mohs micrographic surgery.  Clin Plast Surg. 1993;  20 149-156
• 14 Clark D. Cutaneous micrographic surgery.  Otolaryngol Clin North Am. 1993;  26 185-202
• 15 Chung V Q, Bernardo L, Jiang S B. Presurgical curettage reduces the number of Mohs stages by better delineating the subclinical extensions of tumor margins.  Dermatol Surg. 2005;  31 1094-1099
• 16 Jih M H, Friedman P M, Goldberg L H, Kimyai-Asadi A. Currettage prior to Mohs micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.  Dermatol Surg. 2005;  31 10-15
• 17 Davis D A, Pellowski D M, Hanke C W. Preparation of frozen sections.  Dermatol Surg. 2004;  30 1479-1485
• 18 Murphy M, Brodland D, Zitelli J. The frequency of errors in reading Mohs pathology sections over a one-year fellowship. Paper presented at: Annual Meeting of the Mohs College May 3, 2007 Naples, FL;
• 19 Stein J M, Hrabovsky S, Schuller D E, Siegle R J. Mohs micrographic surgery and the otolaryngologist.  Am J Otolaryngol. 2004;  25 385-393
• 20 Lang Jr P G. The role of Mohs micrographic surgery in the management of skin cancer and a perspective on the management of the surgical defect.  Clin Plast Surg. 2004;  31 5-31
• 21 Touma D J. Mohs' (sic) surgery to reduce the size of facial defects and necessity for complex repairs.  Plast Reconstr Surg. 2002;  110 1601
• 22 Downes R N, Walker N P, Collin J R. Micrographic (Moh's) surgery in the management of periocular basal cell epitheliomas.  Eye. 1990;  4 160-168
• 23 Lane J E, Kent D E. Surgical margins in the treatment of nonmelanoma skin cancer and Mohs micrographic surgery.  Curr Surg. 2005;  62 518-526
• 24 Rowe D E, Carroll R J, Day C L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up.  J Dermatol Surg Oncol. 1989;  15 315-328
• 25 Smeets N W, Krenkels G A, Essers B A et al.. Surgical excision vs. Mohs micrographic surgery for basal cell carcinoma of the face: randomized controlled trial.  Lancet. 2004;  364 1766-1772
• 26 Goldman G D. Squamous cell cancer: a practical approach.  Semin Cutan Med Surg. 1998;  17 80-95
• 27 Rudolph R, Zelac D E. Squamous cell carcinoma of the skin.  Plast Reconstr Surg. 2004;  114 82e-94e
• 28 Marks R. Squamous cell carcinoma.  Lancet. 1996;  347 735-738
• 29 McCombe D, MacGill K, Ainslie J, Beresford J, Matthews J. Squamous cell carcinoma of the lower lip: a retrospective review of the Peter MacCallum Cancer Institute experience 1979–1988.  Aust N Z J Surg. 2000;  70 358-361
• 30 Mahoney E J, Dolan R W, Choi E E, Olbricht S M. Surgical reconstruction of lentigo maligna defects.  Arch Facial Plast Surg. 2005;  7 342-346
• 31 Cohen L M, McCall M W, Hodge S J et al.. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs micrographic surgery aided by rush permanent sections.  Cancer. 1994;  73 2964-2970
• 32 Dawn M E, Dawn A G, Miller S J. Mohs surgery for the treatment of melanoma in situ: a review.  Dermatol Surg. 2007;  33 395-402
• 33 Anderson K W, Baker S R, Lowe L et al.. Treatment of head and neck melanoma, lentigo maligna subtype.  Arch Facial Plast Surg. 2001;  3 202-206
• 34 Zitelli J A, Mohs F E, Larson P, Snow S. Mohs micrographic surgery for melanoma.  Dermatol Clin. 1989;  7 833-843
• 35 Nagi C, O'Grady T C, Izadpanah A. Mohs micrographically controlled surgery and the treatment of malignant melanoma.  Semin Oncol. 2002;  29 336-340
• 36 Harris T J, Hinckley D M. Melanoma of the head and neck in Queensland.  Head Neck Surg. 1983;  5 197-203
• 37 Zitelli J, Brown C D, Hanusa B H. Surgical margins for excision of primary cutaneous melanoma.  J Am Acad Dermatol. 2001;  45 579-586
• 38 Chan F M, O'Donell B A, Whitehead K et al.. Treatment and outcomes of malignant melanoma of the eyelid. A review of 29 cases in Australia.  Ophthalmology. 2007;  114 187-192
• 39 Zalla M J, Lim K K, DiCaudo D J, Gagnot M M. Mohs micrographic excision of melanoma using immunostains.  Dermatol Surg. 2000;  26 771-784
• 40 Albertini J G, Elston D M, Libow F F, Smith S B, Farley M F. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.  Dermatol Surg. 2002;  28 656-665
• 41 Davis D A, Kurtz K A, Robinson R A. Ultrarapid staining for cutaneous melanoma: study and protocol.  Dermatol Surg. 2005;  31(7 Pt 1) 753-756
• 42 Simman R, DeFranzo A, Sanger C, Thompson J. Dermatofibrosarcoma protuberans of the face: surgical management.  J Craniofac Surg. 2005;  16 439-444
• 43 Loss L, Zeitouni N C. Management of scalp dermatofibrosarcoma protuberans.  Dermatol Surg. 2005;  31 1428-1433
• 44 Parker T L, Zitelli J A. Surgical margins for excision of dermatofibrosarcoma protuberans.  J Am Acad Dermatol. 1995;  32 233-236
• 45 Gloster M W, Harris K R, Roenigk R K. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.  J Am Acad Dermatol. 1996;  35 82-87
• 46 Gollard R, Weber R, Kostky M P et al.. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations.  Cancer. 2000;  88 1842-1851
• 47 O'Connor W J, Roenigk R K, Brodland D G. Merkel cell carcinoma—comparison of Mohs micrographic surgery and wide excision in eighty-six patients.  Dermatol Surg. 1997;  23 929-933
• 48 Snow S, Madjar D D, Hardy S et al.. Microcystic adnexal carcinoma; report of 13 cases and review of the literature.  Dermatol Surg. 2001;  27 401-408
• 49 Sebastien T S, Nelson B R, Lowe L et al.. Microcystic adnexal carcinoma.  J Am Acad Dermatol. 1993;  29 840-845
• 50 Clement C I, Genge J, O'Donnell B A, Lochhead A G. Orbital and periorbital microcystic adnexal carcinoma.  Ophthal Plast Reconstr Surg. 2005;  21 97-102
• 51 Davis J L, Randle H W, Zalla M J, Roenigk R K, Brodland D G. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma.  Dermatol Surg. 1997;  23 105-110
• 52 Nelson B R, Hamlet K R, Gillard M et al.. Sebaceous carcinoma.  J Am Acad Dermatol. 1995;  33 1-15
• 53 Ratz J L, Luu-Duong S, Kulwin D R. Sebaceous carcinoma of the eyelid treated with Mohs surgery.  J Am Acad Dermatol. 1986;  14 668-673
• 54 Spencer J M, Nossa R, Tse D T, Sequeira M. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery.  J Am Acad Dermatol. 2001;  44 1004-1009
• 55 Snow S N, Larson P O, Lucarelli M J et al.. Sebaceous carcinoma of the eyelid treated by Mohs surgery: report of nine cases with review of literature.  Dermatol Surg. 2002;  28 623-631
• 56 Cook J, Zitelli J A. Mohs micrographic surgery: a cost analysis.  J Am Acad Dermatol. 1998;  39 698-703
• 57 Bialy T L, Whalen J, Veledar E et al.. Mohs micrographic surgery vs. traditional surgical excision: a cost comparison analysis.  Arch Dermatol. 2004;  140 736-742
• 58 Essers B A, Dirksen C D, Nieman F H et al.. Cost-effectiveness of Mohs micrographic surgery vs. surgical excision for basal cell carcinoma of the face.  Arch Dermatol. 2006;  142 187-194
• 59 Gladstone H B, Stewart D. Algorithm for the reconstruction of complex facial defects.  Skin Therapy Lett. 2007;  12 6-9
• 60 Dobke M K, Miller S H. Tissue repair after Mohs surgery: a plastic surgeon's view.  Dermatol Surg. 1997;  23 1061-1066